Press releases
- Access Reminder for Bruker Investor Webinar on May 17, 2024
- Bruker Announces Quarterly Dividend
- Bruker Corporation to Host Investor Webinar on May 17, 2024
- German Federal Patent Court Invalidates Patent Asserted By 10x Genomics, Delivering Legal Win to NanoString and Bruker
- Bruker Completes Asset Acquisition of NanoString Business
- Bruker Reports First Quarter 2024 Financial Results
- Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech
- Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference
- Bruker Announces Date and Time of First Quarter 2024 Earnings Release and Webcast
- Bruker to Acquire the NanoString Business in an Asset Deal
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | 57.79 |
---|---|
High | 57.79 |
Low | 57.79 |
Bid | 55.63 |
Offer | 56.52 |
Previous close | 57.79 |
Average volume | -- |
---|---|
Shares outstanding | 145.34m |
Free float | 97.10m |
P/E (TTM) | 28.13 |
Market cap | 11.23bn USD |
EPS (TTM) | 2.75 USD |
Annual div (ADY) | 0.183 CHF |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | Feb 29 2024 |
Div pay-date | Mar 15 2024 |
Next div ex-date | Jun 03 2024 |
Next div pay-date | Jun 17 2024 |
Data delayed at least 15 minutes, as of Feb 16 2021.
More ▼